Metformine Biogaran

Metformin, the active ingredient in Metformine Biogaran, is a Biguanide presented as a tablet for oral use. It treats type 2 diabetes mellitus in adults by improving blood‑glucose control. GNH USA supplies Metformine Biogaran as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metformine Biogaran is a Biguanide that targets hyperglycaemia in type 2 diabetes and related metabolic disturbances. - Type 2 diabetes mellitus: lowers fasting and post‑prandial blood glucose levels. - Insulin resistance: improves peripheral insulin sensitivity. - Hepatic glucose output: reduces excessive hepatic glucose production. - Glycaemic variability: helps achieve more stable glucose profiles. - Cardiovascular risk management: contributes to overall metabolic control in diabetic patients.

Metformine Biogaran may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Diarrhoea: loose stools, often early in therapy. - Abdominal discomfort: cramping or bloating. - Metallic taste: transient alteration in taste perception. - Weight loss: modest reduction in body weight. - Vitamin B12 deficiency: reduced absorption with long‑term use.

Serious or Rare Side Effects: - Lactic acidosis: rare but life‑threatening metabolic acidosis. - Severe hypoglycaemia: when combined with insulin or sulfonylureas. - Hepatic failure: rare hepatic dysfunction. - Allergic reactions: rash, pruritus, or angio‑edema. - Myopathy: muscle pain or weakness in rare cases. - Renal impairment worsening: may precipitate accumulation of the drug.

Metformine Biogaran requires careful assessment of patient‑specific factors before initiation. - Renal function: evaluate eGFR; avoid if severe renal impairment. - Lactic acidosis risk: contraindicated in patients with significant cardiac, hepatic, or respiratory disease. - Alcohol consumption: limit intake to reduce acidosis risk. - Pregnancy: category B; use only when benefits outweigh potential risks. - Monitoring: regular HbA1c and renal function tests are recommended. - Store at ambient temperature: keep in the original pack, protect from moisture.

Metformine Biogaran can interact with several medicines, altering its efficacy or safety.

Major Interactions (Avoid): - Iodinated contrast agents: may precipitate renal dysfunction and lactic acidosis. - Cimetidine: increases metformin plasma concentrations. - Alcohol: potentiates risk of lactic acidosis.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may mask hypoglycaemia symptoms. - Loop diuretics: can affect renal clearance of metformin. - ACE inhibitors/ARBs: monitor renal function and electrolytes. - Corticosteroids: may raise blood glucose, requiring dose adjustment. - Thyroid hormones: may influence glucose metabolism.